glucagon like peptide 1 glp 1 Glucagon-like 1, Glucose-Dependent Insulinotropic Polypeptide, and Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Glucagon Like Peptide 1 Receptor
Description
I 2 = 24%)
Why not somebody, why don't you take the question next
Rachele, Restores Chief Science Officer, adds
Canagliflozin (Invokana) Dapagliflozin (Farxiga) Empagliflozin (Jardiance) Ertugliflozin (Steglatro) These medications are effective in lowering the A1c, which helps to protect heart and kidney function
The findings warrant more study into this potential side effect and why it may be happening, the researchers say
